An analysis of IL-36 signature genes and individuals with knockout mutations validates IL-36 as a psoriasis therapeutic target. (2017)

First Author: Mahil SK

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aan2514

PubMed Identifier: 29021166

Publication URI: http://europepmc.org/abstract/MED/29021166

Type: Journal Article/Review

Volume: 9

Parent Publication: Science translational medicine

Issue: 411

ISSN: 1946-6234